GLP-1 SEMAGLUTIDE & TIRZEPATIDE

Semaglutide & Tirzepatide, are GLP-1 (glucagon-like peptide-1) receptor agonists, is a breakthrough treatment for weight loss. Initially used for managing type 2 diabetes, semaglutide has shown remarkable efficacy in promoting weight loss by regulating appetite and food intake. This innovative medication mimics the hormone GLP-1, which plays a crucial role in appetite control and digestion

How Long to See Results:

Patients typically begin to notice weight loss within the first few weeks of treatment. Maximum results are often seen after several months of consistent use, with many individuals experiencing significant weight loss within 3 to 6 months.

Most people experience a gradual decrease in weight within the first few weeks of Semaglutide or Tirzepatide use. Studies show an average weight loss of 5-10% in one year, with some individuals achieving even greater results.

• What is Semaglutide and Tizepatide? Semaglutide and Tirzepatide are both GLP-1 receptor agonists that help regulate appetite and promote weight loss.
• How does Semaglutide and Tizepatide work for weight loss? Semaglutide and Tizepatide mimic the GLP-1 hormone, which controls hunger and slows digestion, reducing food intake and weight loss.
• How long should I take Semaglutide and Tizepatide? Your healthcare provider will determine the appropriate duration based on your weight loss goals and health status.
• Are there any side effects? Common side effects include nausea, vomiting, and diarrhea, which often diminish over time. Always consult your doctor if you experience any adverse effects.
• Is Semaglutide suitable for everyone? Semaglutide and Tizepatide are generally recommended for adults with a BMI of 30 or higher, or those with a BMI of 27 or higher with weight-related health issues.